Back to results
US 2026/0216190 A1Published application
Treatment of hematological malignancies with inhibitors of menin
AssigneeKura Oncology, Inc.
InventorFrancis BURROWS
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for treating hematological malignancies using menin inhibitors. Compositions for use in these methods are also provided.
Claims21
-145. (canceled)
A method of treating acute myeloid leukemia in a subject exhibiting KIT dependence comprising administering a menin inhibitor to the subject.
Dependencies are inferred from the claim text.